Vanberra Signal

Lyceum

Curated by Signal

AI-driven theoretical and experimental systems biology to understand disease and develop therapeutics

Overview

Lyceum is leveraging the research of evolutionary biologist, Michael Rose at the UC Irvine to create an AI-driven experimental and analytical framework to gain deep insights into aging and associated chronic diseases to find biomarkers and therapeutics. The company's primary tools include a large collection of Drosophila populations that are derived from natural outbred populations and can be used as disease models and novel statistical approaches to determining the most important genomic sites and pathways underlying chronic diseases. The company is partnering with BluePrint Bio, a biomarker discovery company, and Emerald Logic, which has developed a precision analytics platform for integrated multi-omic discovery.

Key facts

Founded
2015

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of therapies and devices for acute brain, cardiovascular and respiratory diseases

    Life Sciences TechnologyLas Vegas, United States
  • Online platform offering laboratory testing and genome analysis solutions for healthcare providers

    Life Sciences TechnologyAustin, United States
  • Developer of smart devices for treating pulmonary diseases

    Life Sciences TechnologyRedwood City, United States

About Lyceum

What does Lyceum do?

Lyceum is leveraging the research of evolutionary biologist, Michael Rose at the UC Irvine to create an AI-driven experimental and analytical framework to gain deep insights into aging and associated chronic diseases to find biomarkers and therapeutics.

Where is Lyceum headquartered?

Lyceum is headquartered in Los Angeles, United States.

When was Lyceum founded?

Lyceum was founded in 2015.

Which sector is Lyceum in?

Lyceum operates in Life Sciences Technology.

Who are Lyceum's competitors?

Companies similar to Lyceum include Odyssey Health, GX Sciences, and Pulmonx.